New results show a much shorter treatment regimen for drug-resistant TB is superior to current care TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières/Doctors Without Borders (MSF) has found that a new all-oral six-month treatment regimen is safer and more effective at treating...
